Project Name: annual production of nucleoside (acid) series products, vitamin B1 intermediate, B5 intermediate products and acetonitrile project of Xinxiang Ruinuo Pharmaceutical Co., Ltd
Product Name: magnetic pump, tangent flow pump
Project location: Xinxiang, Henan
Cooperation unit: Henan Xinxiang Ruinuo Pharmaceutical Co., Ltd

Xinxiang Ruinuo Pharmaceutical Co., Ltd. is jointly invested and established by Shanghai chuangnao Pharmaceutical Group's Pusheng Investment Development Center, Henan xinlianxin Investment Co., Ltd. and Xinxiang Ruicheng Technology Co., Ltd.

The project mainly focuses on the development and production of new raw materials and key intermediates for the two main lines of new anti AIDS, anti HBV drugs and new B vitamins. It is expected to be implemented in three phases, with a total investment of about 1 billion yuan. The plan is to start IPO in 2020 and sign the gem in 2022.

The company adopts the domestic advanced production technology and equipment in the same industry, and has high-quality technology and management talents. At the same time, it has advanced testing equipment for product quality testing and control, which has laid a solid foundation for ensuring product quality. The products are sold well in large and medium-sized raw material medicine and vitamin production enterprises at home and abroad, and are highly praised by users.

In the spirit of keeping pace with the times, advocating innovation and pursuing excellence, the company always adheres to the enterprise tenet of market-oriented, talent based, product based, management linked, innovation as the soul, refinement as the pursuit and development as the goal, constantly improves the scientific management system of production and operation, technology research and development and sales service, and strengthens the company's knowledge-based, innovative, innovative and innovative management The professional and young enterprise team focuses on repetition and innovation on the road of pharmaceutical intermediates, and provides customers with high-quality and efficient products and services.

Product Name: magnetic pump, tangent flow pump
Project location: Xinxiang, Henan
Cooperation unit: Xinxiang Ruicheng Technology Co., Ltd

Xinxiang Ruicheng Technology Co., Ltd. is a joint-stock enterprise, located in the east section of Qinglong Road, Xinxiang economic development zone. It is a new technology enterprise integrating development, research, production and sales. In 2015, the company passed the high-tech enterprise certification, and obtained the provincial R & D center certification in the same year: in 2016, the company was successfully listed on the new third board, officially entered the capital market, and entered the innovation level in May 2018; In March 2017, he and Shanghai Chuang Nuo Pharmaceutical Group jointly established a subsidiary: Xinxiang Ruinuo Pharmaceutical Co., Ltd.

The products are mainly used in the production of nucleoside API, antiviral API, perindopril API and vitamins. The company adopts the professional production technology and equipment of the same industry in China, and has high-quality technology and management personnel. It also works closely with national scientific research institutions and high-level hospital control, and has professional testing equipment for product quality testing and control, In order to ensure the quality of products laid a solid foundation, products sell well at home and abroad large and medium-sized API, vitamin production enterprises, and well received by users.

In 2014, the company passed ISO9001:2008 quality management system certification and iso14001:2014 environmental management system certification. In the spirit of keeping pace with the times, advocating innovation and pursuing excellence, the company always adheres to the enterprise tenet of taking the market as the guide, taking talents as the foundation, relying on products, taking management as the link and taking development as the goal, constantly improves the scientific management system of production, operation and sales service, and strengthens the company's knowledgeable, professional and young enterprise team, In the pharmaceutical intermediates on the road to continuous innovation, to provide customers with efficient service.